Literature DB >> 4137661

Familial clustering of hepatitis B antigen: a study in relatives of patients with liver diseases and hepatitis B antigenaemia.

M Bruguera, J Bosch, J Rodés, J Pedreira.   

Abstract

Twelve of the 100 family contacts of 29 patients with transient and persistent hepatitis B antigenaemia were found to be positive for hepatitis B antigen (HBAg). No relation was found between familial clustering and the nature of liver disease or the duration of antigenaemia in the index cases.Eight affected relatives were apparently healthy carriers of HBAG, one had cirrhosis, and three (in the same family) developed acute viral hepatitis.The absence of parenteral exposure in the HBA,-positive family contacts and the identity in antigenic determinants d or y with those of the index cases, suggest a non-parenteral spread of HBAg in families of patients with HBAg-associated liver diseases.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4137661      PMCID: PMC1611186          DOI: 10.1136/bmj.3.5929.495

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  18 in total

1.  Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection.

Authors:  S Krugman; J P Giles; J Hammond
Journal:  JAMA       Date:  1967-05-01       Impact factor: 56.272

2.  Menstrual blood as a vehicle of Australia-antigen transmission.

Authors:  S Mazzur
Journal:  Lancet       Date:  1973-04-07       Impact factor: 79.321

3.  Absence of Au antigen in faeces of patients with Au-positive sera.

Authors:  I D Gust; J Kaldor; M Nastasi
Journal:  Lancet       Date:  1971-04-17       Impact factor: 79.321

4.  Viral hepatitis. New light on an old disease.

Authors:  S Krugman; J P Giles
Journal:  JAMA       Date:  1970-05-11       Impact factor: 56.272

5.  The epidemiology of serum hepatitis (SH) infections: a controlled study in two closed institutions.

Authors:  W Szmuness; A M Prince
Journal:  Am J Epidemiol       Date:  1971-12       Impact factor: 4.897

Review 6.  Changing concepts in the epidemiology of viral hepatitis.

Authors:  R S Koff; K J Isselbacher
Journal:  N Engl J Med       Date:  1968-06-20       Impact factor: 91.245

7.  Nonparenteral transmission of viral hepatitis type B (Australia antigen-associated serum hepatitis).

Authors:  T Hersh; J L Melnick; R K Goyal; F B Hollinger
Journal:  N Engl J Med       Date:  1971-12-09       Impact factor: 91.245

8.  Faecal S.H. (Australia) antigen in acute hepatitis.

Authors:  P J Grob; H Jemelka
Journal:  Lancet       Date:  1971-01-30       Impact factor: 79.321

9.  Studies of Australia-SH antigen in sporadic viral hepatitis in London.

Authors:  Y E Cossart; J Vahrman
Journal:  Br Med J       Date:  1970-02-14

10.  Hepatitis and Australia antigen: autosomal recessive inheritance of susceptibility to infection in humans.

Authors:  B S Blumberg; J S Friedlaender; A Woodside; A I Sutnick; W T London
Journal:  Proc Natl Acad Sci U S A       Date:  1969-04       Impact factor: 11.205

View more
  5 in total

1.  Familial clustering and immune response in family contacts of patients with HBsAg-positive liver cirrhosis.

Authors:  M Eliakim; M Ligumski; S G Sandler; A Zlotnick
Journal:  Am J Dig Dis       Date:  1978-05

2.  The case for not giving gamma globulin in all exposure to hepatitis B.

Authors:  F Hamilton; F L Iber
Journal:  Am J Dig Dis       Date:  1976-05

3.  Chronicity rate of hepatitis B virus infection in the families of 60 hepatitis B surface antigen positive chronic carrier children: role of horizontal transmission.

Authors:  A Vegnente; R Iorio; S Guida; L Cimmino
Journal:  Eur J Pediatr       Date:  1992-03       Impact factor: 3.183

4.  Familial clustering of hepatitis B antigen and liver diseases in families with a high incidence of viral hepatitis.

Authors:  F Piccinino; G Manzillo; E Sagnelli; G Balestrieri; G Maio
Journal:  Infection       Date:  1975       Impact factor: 3.553

Review 5.  Hepatitis in nursing homes. Incidence and management strategies.

Authors:  A Floreani; M Chiaramonte
Journal:  Drugs Aging       Date:  1994-08       Impact factor: 3.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.